News | January 12, 2023
Apollo Genomics Institutes launched at Apollo Hospitals Navi Mumbai
Launch of Apollo Genomics Institutes would provide genetic counselling, tests, treatment and care for genetic disorders
Launch of Apollo Genomics Institutes would provide genetic counselling, tests, treatment and care for genetic disorders
The JUST 100 is the only ranking that recognizes companies doing right by all their stakeholders as defined by the American public.
Collaboration to generate and develop therapeutics for oncology and non-oncology conditions
The objective of this system is to shift the focus of measuring performance of hospitals from volume of services provided to value of healthcare services
In a time when conversations around mental health have become ever more urgent Vaidya’s work is extremely contextual
The new project further expands the partner's long-term collaboration on new technologies for R&D
A study by Agharkar Research Institute (ARI), Pune, has discovered that a protein secreted from intervertebral disc cells induces disc regeneration in aged degenerated discs
Fesoterodine Fumarate Extended-Release Tablets, 4 mg and 8 mg, (RLD Toviaz®) had estimated annual sales of USD 177 million in the U.S. (IQVIA MAT September 2022).
Zydus is the first company to receive final approval and launch Topiramate Extended-Release Capsules, USP 25 mg, 50 mg, and 100 mg in the United States.
Fesoterodine Fumarate Extended-Release Tablets, 4 mg and 8 mg, have an estimated market size of US$ 177 million for twelve months ending Sep 2022
Subscribe To Our Newsletter & Stay Updated
